Comparison of two automated ApoE4 proteotype immunoassays
ApoE4 proteotype immunoassays may represent simplified and more accessible testing alternatives to genotyping for the assessment of ApoE4 zygosity in individuals being considered for amyloid lowering treatments.
Authors
- Susan Ashrafzadeh‐Kian (ORCID: https://orcid.org/0000-0003-2991-129X)
- Alicia Algeciras‐Schimnich (ORCID: https://orcid.org/0000-0002-4455-6217)
- Joshua A. Bornhorst (ORCID: https://orcid.org/0009-0003-9297-3271)
- Daniel J. Figdore (ORCID: https://orcid.org/0000-0002-4776-3203)
Institutions
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_100528
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00